Perimeter Medical Imaging AI (TSX-V: PINK; OTCQX: PYNKF) has announced that Michelle Caron, CPA, has been appointed to its board of directors (BOD), effective immediately. In a finance career spanning more than 28...
AI/ML Innovations (CSE: AIML; OTCQB: AIMLF; FWB: 42FB) has appointed Lynn Chapman, CPA, CA, as chief financial officer (CFO), effective October 1, 2026. Mr. Chapman brings more than 15 years of financial and managerial...
Surrozen (NASDAQ: SRZN) has announced its Investigational New Drug (IND) application for SZN-8141 for the treatment of diabetic macular edema (DME) has become effective, enabling advancement to clinical development. SZN...
Tenon Medical (NASDAQ: TNON) has announced the full commercial launch of its new titanium 3D-printed lateral screw as part of the SImmetry+ SI Joint Fusion System following the successful completion of the...
Connect Biopharma (NASDAQ: CNTB) has announced topline results from its global Phase 2 study evaluating rademikibart, its next-generation, potentially best-in-class anti-interleukin-4-receptor alpha (IL-4Rα) antibody as...
Immix Biopharma (NASDAQ: IMMX) has reported interim data showing an 89% complete response (CR) rate across all 45 enrolled patients, based on an assessment by an independent review committee, from its NEXICART-2 Phase 2...
Nexalin Technology (NASDAQ: NXL) has announced the appointment of Robert DiTota as senior strategic advisor, global commercialization, effective September 15, 2026. Mr. DiTota brings more than 20 years of neuroscience...
Akebia Therapeutics (NASDAQ: AKBA) is advancing the Nobel Prize-winning science behind hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) through its commercial product, Vafseo, an oral therapy designed...
Codexis (NASDAQ: CDXS) has announced an agreement with a pioneering siRNA drug innovator to explore stereo-defined fragment synthesis using its ECO Synthesis Manufacturing Platform. According to Codexis, the agreement...
DataMeds AI (NASDAQ: MEDS) and closely held Tollo Health have announced the launch of the Health Lives Here mobile application (app), initially focused on supporting users of GLP-1 receptor agonist medications...